Politician trade (Senate)

HCA Healthcare (HCA)Sen. Alan Armstrong disclosed a purchase $1K–$15K

Sen. Alan Armstrong disclosed a purchase of HCA Healthcare in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
116 days
Disclosure lag
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 27, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  2. Feb 3, 2026Insider · 2 peopleInsiders: 8 sales (~$22.2M)
  3. Feb 10, 20265% stakeThomas F. Frist, Jr. filed an activist stake (13D) of 31.6%
  4. Feb 11, 2026Insider · 2 peopleInsiders: 3 sales (~$6.1M)
  5. Feb 18, 2026InsiderOfficer sold ~$904K of HCA shares in the open market
  6. Feb 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 24, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of HCA Healthcare, Inc. (the “Company”) adopted the 2026 Executive Officer Performance Excellence Program (the “Executive Officer PEP”).”
  7. Mar 27, 2026 · this disclosureCongressDisclosed purchase of HCA — reported range $1,001 - $15,000

What came next

  1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  2. Apr 24, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  3. Apr 27, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  4. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 5.3%
  5. Jun 15, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 15, 2026, Dr. Michael Cuffe and HCA Healthcare, Inc. (the “Company”) agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027.”
  6. Jul 14, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  7. Jul 24, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for HCA Healthcare

For HCA Healthcare, OQRO holds 3 Congress trade reports and 29 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCA page.

Other recent filings by Sen. Alan Armstrong

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

Other disclosures at HCA Healthcare

Everything OQRO holds on this company is on its HCA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data